Search clinical trials for: M4344+Niraparib
Total 219 results
-
Massachusetts General HospitalUniversity of Pennsylvania; Duke University; Sibley Memorial HospitalRecruitingBreast Cancer | Triple Negative Breast CancerUnited States
-
Ivy Brain Tumor CenterGlaxoSmithKlineNot yet recruitingGlioblastoma | Brain Tumor | GBM | Brain Neoplasms, Adult, Malignant
-
GlaxoSmithKlineActive, not recruitingLung Cancer, Non-Small CellArgentina, France, Spain, Italy, Belgium, Korea, Republic of, United States, Mexico, Hungary, Sweden, Turkey, Ireland, Greece, Russian Federation, Germany, Netherlands, Bulgaria, Romania, Brazil, United Kingdom, Poland, Australia, C... and more
-
Janssen Research & Development, LLCApproved for marketingMetastatic Castration-resistant Prostate CancerBrazil, Austria, Estonia, Israel, Mexico
-
Rohan GarjeJanssen Scientific Affairs, LLCNot yet recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Joseph Caster, Ph.D., M.D.GlaxoSmithKlineRecruitingRectal Neoplasms | Rectal Neoplasm MalignantUnited States
-
Novartis PharmaceuticalsCompletedInfectionsGermany, Austria, Italy, Russian Federation, Spain
-
Janssen Research & Development, LLCActive, not recruitingProstatic Neoplasms, Castration-ResistantBelgium, United States, United Kingdom, Canada, Israel, Spain, Italy
-
CanariaBio Inc.Veristat, LLCActive, not recruitingPeritoneal Cancer | Recurrent Ovarian Cancer | Recurrent Fallopian Tube Cancer | Recurrent Epithelial Cancer of Ovary | Recurrent Epithelial Ovarian Cancer | Recurrent Carcinoma of Ovary | Adenocarcinoma of OvaryUnited States
-
Emory UniversityNational Cancer Institute (NCI); GlaxoSmithKline; National Institutes of Health...Active, not recruitingMicrosatellite Stable | Stage IV Colorectal Cancer AJCC v8 | RAS Wild Type | MSI-H Colorectal Cancer | Metastatic Microsatellite Stable Colorectal Carcinoma | Advanced Microsatellite Stable Colorectal CarcinomaUnited States
-
University Health Network, TorontoRecruitingEndometrial Carcinoma | P53 Mutation | Serous CarcinomaCanada
-
Peking Union Medical College HospitalZai Lab (Shanghai) Co., Ltd.Unknown
-
University of Alabama at BirminghamTerminatedOvarian Cancer | Resistant BRCA Wild-Type Ovarian CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingProgressive Disease | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial Carcinoma | Endometrial Adenocarcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Platinum-Resistant Ovarian Carcinoma | High Grade Ovarian... and other conditionsUnited States
-
Qian QinJanssen, LP; UT Southwestern Comprehensive Cancer CenterNot yet recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | BRIP1 Gene Mutation | PALB2 Gene Mutation | CHEK2 Gene Mutation | FANCA Gene Mutation | RAD51B Gene Mutation | RAD54L Gene Mutation | Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | Deleterious HRR Gene Mutation
-
University of California, San FranciscoGlaxoSmithKlineRecruitingMetastatic Solid Tumor | BRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | ATM Gene MutationUnited States
-
University of British ColumbiaUniversity Health Network, Toronto; Janssen Inc.RecruitingGenomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer (GUNS)Prostate CancerCanada, United States
-
University of PennsylvaniaTesaro, Inc.; NovoCure Ltd.Active, not recruiting
-
Nordic Society of Gynaecological Oncology - Clinical...Massachusetts General Hospital; University of Utah; European Network of Gynaecological... and other collaboratorsCompletedOvarian CancerUnited States, Denmark
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyNot yet recruitingOvarian CancerUnited States, Germany
-
Tesaro, Inc.Completed
-
Xiaoxiang ChenUnknownNeoplasms | Neoplasms by Histologic Type | Urogenital Neoplasms | Neoplasms by Site | Carcinoma | Neoplasms, Glandular and Epithelial | Genital Neoplasms, Female | Endocrine System Diseases | Ovarian Diseases | Adnexal Diseases | Gonadal Disorders | Endocrine Gland Neoplasms | Ovarian Neoplasms | Fallopian Tube Neoplasms and other conditionsChina
-
University of OklahomaGlaxoSmithKlineRecruitingRecurrent Ovarian Carcinoma | Recurrent Endometrial Carcinoma | ARID1A Gene MutationUnited States
-
MedSIRGlaxoSmithKlineCompletedBreast Cancer | Breast Cancer MetastaticSpain
-
ARCAGY/ GINECO GROUPRecruitingOvarian CancerJapan, France
-
Tesaro, Inc.Completed
-
Universitaire Ziekenhuizen KU LeuvenEuropean CommissionCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaGermany, Belgium, Italy, Austria, France
-
Tesaro, Inc.Terminated
-
Shanghai Gynecologic Oncology GroupFudan UniversityNot yet recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaChina
-
AstraZenecaCompletedBipolar I DisorderUnited States, Sweden, Bulgaria, France, Italy, Poland, Russian Federation, South Africa, Spain, Turkey, United Kingdom, Germany, Czech Republic, Hungary, Finland, Norway, Australia, Belgium
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Bayer; Janssen, LP; Prostate Cancer Clinical Trials ConsortiumCompletedStage IV Prostate Adenocarcinoma | Hormone-refractory Prostate Cancer | Prostate Carcinoma Metastatic to the BoneUnited States
-
European Organisation for Research and Treatment...Active, not recruitingCarcinoma, Squamous Cell of Head and NeckFrance, Spain, Belgium, Italy, United Kingdom
-
Tesaro, Inc.Active, not recruiting
-
Johns Hopkins UniversityCairo University; United States Agency for International Development (USAID); World Health Organization and other collaboratorsCompletedStreptococcal Infections | PharyngitisEgypt, Croatia, Brazil
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker and other collaboratorsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Sweden, Belgium, Switzerland, Norway
-
Canadian Cancer Trials GroupRecruiting
-
AGO Study GroupEuropean Network of Gynaecological Oncological Trial Groups (ENGOT)RecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerGermany
-
City of Hope Medical CenterNational Cancer Institute (NCI)Not yet recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian CarcinomaUnited States
-
University Health Network, TorontoGlaxoSmithKlineRecruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | High Grade Serous Cancer | High Grade Endometrioid CancerCanada
-
Tesaro, Inc.Terminated
-
Nordic Society of Gynaecological Oncology - Clinical...WithdrawnOvarian CancerNorway, Denmark, Finland
-
UNICANCERCancer Research UK; National Cancer Institute, France; Servier; Pierre Fabre Medicament and other collaboratorsNot yet recruitingBiliary Tract NeoplasmsUnited Kingdom, France, Belgium
-
Hoffmann-La RocheGilead Sciences, Inc., GlaxoSmithKline plc, Seattle Genetics and AstellasRecruitingBladder Cancer | Urothelial CarcinomaUnited States, Spain, Korea, Republic of, United Kingdom, Taiwan, France, Greece
-
Janssen Research & Development, LLCActive, not recruitingProstatic NeoplasmsBelgium, Netherlands, Spain, Sweden, Poland, United States, France, Georgia, Moldova, Republic of, United Kingdom, Ukraine
-
Tarveda TherapeuticsRecruitingNeoplasms | Carcinoma | Small Cell Lung Carcinoma | Gastric Cancer | Pancreatic Adenocarcinoma | Solid Tumor | Gastric Adenocarcinoma | Small-cell Lung Cancer | Advanced Cancer | Pancreatic Ductal Adenocarcinoma | Adenocarcinoma of the Pancreas | Endometrial Adenocarcinoma | Squamous Cell Carcinoma of the Penis | Gastroesophageal... and other conditionsUnited States
-
Janssen Research & Development, LLCCompletedProstatic NeoplasmsUnited States, Canada
-
Tesaro, Inc.RecruitingOvarian NeoplasmsSpain, United States, Canada
-
University College, LondonNovartis; Cancer Research UK; Janssen Pharmaceutica NVNot yet recruiting
-
M.D. Anderson Cancer CenterActive, not recruitingStage III Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Neuroendocrine Carcinoma | Stage IIIC Lung Cancer AJCC v8 | Lung Small Cell CarcinomaUnited States
-
Wake Forest University Health SciencesTesaro, Inc.Withdrawn